Accès gratuit
Med Sci (Paris)
Volume 18, Numéro 11, Novembre 2002
Page(s) 1095 - 1101
Section M/S Revues : Articles de Synthèse
Publié en ligne 15 novembre 2002
  1. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women : association with slimming regimen including Chinese herbs. Lancet 1993; 341 : 387–91.
  2. Vanhaelen M, Vanhaelen-Fastre R, But P, Vanherweghem JL. Identification of aristolochic acid in Chinese herbs. Lancet 1994; 343 : 174.
  3. Mengs U. Acute toxicity of aristolochic acid in rodents. Arch Toxicol 1987; 59 : 328–31.
  4. Jackson L, Kofman S, Weiss A, Brodovsky H. Aristolochic acid [NSC-50413] : phase I clinical study. Cancer Chemother 1964; 42 : 35–7.
  5. Vanherweghem JL. Misuse of herbal remedies : the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Compl Med 1998; 4 : 9–13.
  6. Stephanovic V, Polenakovic MH. Balkan nephropathy : kidney disease beyond the Balkans. Am J Nephrol 1991; 11 : 1–11.
  7. Reginster F, Jadoul M, Van Ypersele De Strihou C. Chinese herbs nephropathy : presentation, natural history and fate after transplantation. Nephrol Dial Transpl 1997; 12 : 81–6.
  8. Vanherweghem JL, Cuykens JJ, Vandenbergh P, Bouman KP, Hagers Y. Valvular heart disease and Chinese herb nephropathy. Lancet 1998; 351 : 991.
  9. Gillerot G, Jadoul M, Arlt VM, et al. Aristolochic acid nephropathy in a Chinese patient : time to abandon the term « Chinese Herbs Nephropathy ». Am J Kidney Dis 2000; 38 : E 26.
  10. Pourrat J, Montastruc JL, Lacombe JL, Cisterne JM, Rascol O, Dumazer P. Néphropathie associée à des herbes chinoises : 2 cas. Presse Med 1994; 23 : 1669.
  11. Stengel B, Jones E. Insuffisance rénale terminale associée à la consommation d’herbes chinoises en France. Néphrologie 1998; 19 : 15–20.
  12. Pêna JM, Borras M, Ramos J, Montoliu J. Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion. Nephrol Dial Transpl 1996; 11 : 1359–60.
  13. Tanaka A, Nishida R, Maeda K, Sugawara A, Kuwahara T. Chinese herb nephropathy in Japan presents adult onset Fanconi syndrome : could different components of aristolochic acids cause a different type of Chinese herb nephropathy ? Clin Nephrol 2000; 53 : 301–6.
  14. Tanaka A, Nishida R, Yoshida T, Koshikawa M, Goto M, Kuwahara T. Outbreak of Chinese herb nephropathy in Japan : are there any difference from Belgium ? Intern Med 2001; 40 : 296–300.
  15. Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354 : 481–2.
  16. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001; 358 : 1515–6.
  17. Cronin AJ, Maidment G, Cook T, et al. Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol Dial Transpl 2002; 17 : 524–5.
  18. Yang CS, Lin CH, Chang SH, Hsu HC. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000; 35 : 313–8.
  19. Chang CH, Wang YM, Yang AH, Chiang SS. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 2001; 21 : 441–8.
  20. Yang SS, Chu P, Lin YF, Chen A, Lin SH. Aristolochic acid-induced Fanconi’s syndrome and nephropathy presenting as hypokalemic paralysis. Am J Kidney Dis 2002; 39 : E 14.
  21. Meyer MM, Chen TP, Bennet WM. Chinese herb nephropathy. BUMC Proc 2000; 13 : 334–7.
  22. Krumme B, Endmeir R, Vanhaelen M, Walb D. Reversible Fanconi syndrome after ingestion of a Chinese herbal « remedy » containing aristolochic acid. Nephrol Dial Transpl 2001; 16 : 400–2.
  23. Cosijns JP, Jadoul M, Squifflet JP, et al. Chinese herbs nepropathy : a clue to Balkan endemic nephropathy ? Kidney Int 1994; 45 : 1680–8.
  24. Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994; 24 : 172–80.
  25. Mengs U, Lang W, Poch JA. The carcinogeric action of aristolochic acid in rats. Arch Toxicol 1982; 51 : 107–19.
  26. Cosyns JP, Jadoul M, Squifflet JP, Van Cangh PJ, Van Ypersele De Strihou C. Urothelial malignancy in nephropathy due to Chinese herbs. Lancet 1994; 344 : 188.
  27. Vanherweghem JL, Tielemans C, Simon J, Depierreux M. Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transpl 1995; 10 : 270–3.
  28. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, Van Ypersele De Strihou C. Urothelial lesions in Chinese herb nephropathy. Am J Kidney Dis 1999; 33 : 1011–7.
  29. Nortier J, Muniz Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000; 342 : 1686–92.
  30. Cosyns JP, Goebbels RM, Liberton V, Schmeiser HH, Bieler CA, Bernard AM. Chinese herbs nephropathy associated slimming regimen induces tumours in the forestomach but not interstitial nephropathy in rats. Arch Toxicol 1998; 72 : 738–43.
  31. Cosyns JP, Dehoux JP, Guiot Y, et al. Chronic aristolochic acid toxicity in rabbits : a model of Chinese herb nephropathy ? Kidney Int 2001; 59 : 2164–73.
  32. Debelle FD, Nortier J, Deprez E, et al. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt depleted rats. J Am Soc Nephrol 2002; 13 : 431–6.
  33. Muniz Martinez MC, Nortier J, Vereerstraeten P, Vanherweghem JL. Progression rate of Chinese herb nephropathy : impact of Aristolochia fangchi ingested dose. Nephrol Dial Transpl 2002; 17 : 408–12.
  34. Kabanda A, Jadoul M, Lauwerys R, Bernard A, Van Ypersele De Strihou C. Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int 1995; 48 : 1571–6.
  35. Nortier JL, Deschodt-Lanckman MM, Simon S, et al. Proximal tubular injury in Chinese herb nephropathy : monitoring by neutral endopeptidase enzymuria. Kidney Int 1997; 51 : 288–93.
  36. Tanaka A, Nishida R, Yokoi H, Kuwahara T. The characteristic pattern of aminoaciduria in patients with aristolochic acid-induced Fanconi syndrome : could iminoaciduria be the hallmark of this syndrome ? Clin Nephrol 2000; 54 : 198–202.
  37. Lebeau C, Arlt VM, Schmeiser HH, et al. Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells. Kidney Int 2001; 60 : 1332–42.
  38. Arlt VM, Pfohl-Leszkowicz A, Cosyns JP, Schmeiser HH. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutat Res 2001; 494 : 143–50.
  39. Schmeiser HH, Bieler CA, Wiessler M, Van Ypersele De Srihou C, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 1996; 56 : 2025–8.
  40. Stiborova M, Frei E, Wiessler M, Schmeiser HH. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids : evidence for reductive activation by cytochromes P4501A1 and 1A2. Chem Res Toxicol 2001; 14 : 1128–37.
  41. Schmeiser HH, Scherf HR, Wiessler M. Activating mutations at codon 61 of the c-Ha-ras gene in thin tissue sections of tumors induced by aristolochic acid in rats and mice. Cancer Lett 1991; 59 : 139–43.
  42. Vanherweghem JL, Abramowicz D, Tielemans C, Depierreux M. Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis : a pilot study in Chinese herb nephropathy. Am J Kidney Dis 1996; 27 : 209–15.
  43. Stiborova M, Frei E, Breuer A, Wiessler M, Schmeiser HH. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthetase- 32P- postlabeling analysis of DNA adduct formation. Mutat Res 2001; 493 : 149–60.
  44. Vanherweghem JL. Aristolochia sp and chronic interstitial nephropathies in Indians. Lancet 1997; 349 : 1399.
  45. Vanherweghem JL. Nephropathy and herbal medicine. Am J Kidney Dis 2000; 35 : 330–2.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.